0.1950SEK+3.17%Mkt Cap: 12.55M $P/E: —1d ago
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins a…
Indicators:|
Key Statistics
Company
Market Cap12.55M $
Enterprise Value7.23M $
Revenue (TTM)88.00K $
Gross Profit52.51K $
Net Income (TTM)-13.96M $
Revenue/Share0.0002 USD
Last Price0.1950 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees17
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISINSE0006091997
Valuation
P/E (Trailing)—
P/E (Forward)0.03
PEG—
EV/EBITDA-0.94
EV/Revenue82.13
P/S142.58
P/B2.83
EPS (TTM)-0.26
EPS (Forward)7.00
52W Range
0.15027% of range0.7527
52W High0.7527 SEK
52W Low0.1502 SEK
Profitability
Gross Margin80.15%
Oper. Margin-4942.25%
EBITDA Margin0.00%
Profit Margin-21301.46%
ROE-225.30%
ROA-165.41%
Growth
Revenue Growth169.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.50M $
CapEx (TTM)531.73K $
FCF Margin-4111.52%
FCF Yield-28.84%
Net Debt-5.32M $
Net Debt/EBITDA0.69
Balance Sheet
Debt/Equity0.01
Current Ratio3.05
Quick Ratio3.04
Book Value/Sh0.0690 SEK
Cash/Share0.0830 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:100
Split DateFeb 3, 2026
Analyst Consensus
Rating—
Target (Mean)0.4200 SEK
Upside (mean)+115.4%
Target Range0.4200 SEK – 0.4200 SEK
# Analysts1
Ownership
Shares Out.672.67M
Float607.39M
Insiders10.70%
Institutions17.70%
Technical
SMA 500.1973 (-1.2%)
SMA 2000.2337 (-16.6%)
Beta2.68
S&P 52W Chg20.05%
Avg Vol (30d)3.80M
Avg Vol (10d)2.64M
Technical Indicators
RSI (14)49.8
MACD-0.0006
MACD Signal-0.0012
MACD Hist.+0.0006
BB Upper0.2105 SEK
BB Middle0.1932 SEK
BB Lower0.1760 SEK
BB Width17.87%
ATR (14)0.0152 SEK
Vol Ratio (20d)0.40x